Skip to content
Founder TaxPartners

Growth Shares and Unapproved Options Explained

11 November 2026 · 9 min read

Get in touch

When EMI is off the table, whether the company is too big, in the wrong trade, or the recipient is an adviser rather than an employee, growth shares are usually the next tool a UK founder reaches for. They're easy to get wrong, and the mistakes are expensive: a hurdle valuation that won't stand up, or a missed 14-day election that turns a capital gain into income. Worked examples use illustrative figures throughout.

What growth shares are

Growth shares are a separate class of shares that only deliver value above a set hurdle: the current market value of the company at the date of grant. Because the shares only participate in value above that hurdle, employees or advisers receive a share of future growth rather than existing equity, and the shares have little or no monetary value on day one. They fall under general employment-related-securities (ERS) rules for tax purposes, not under any statutory tax-advantaged scheme.

So they're mostly used where EMI can't be (the company's outside the tests, or the person isn't an employee), and sometimes simply because the founders want new holders to share only in growth from here, not in what's already been built.

The hurdle mechanic

The hurdle is the value the company must reach before growth shares participate in any proceeds. It's set at the current market value of the company at the date of grant, backed by an independent valuation done at the time. HMRC's Shares and Assets Valuation team won't agree it in advance: its pre-grant service covers EMI, SIP, CSOP and SAYE shares only (gov.uk, get a share scheme valuation). Because growth shares carry a right only to value above that hurdle, their standalone market value at grant is low or zero. This low acquisition value is what makes the structure tax-efficient: there's little or no income tax charge at the point the shares are issued.

The hurdle is a structural feature of the share class, not a formula that can be stated as a rule. The precise mechanics depend on the company's articles, the shareholders' agreement, and any ratchet or waterfall provisions. Getting the hurdle right takes professional advice and a valuation you'd be happy to defend if HMRC asks, because there's no advance agreement to fall back on.

Worked example: how the hurdle splits exit proceeds

Event Illustrative figure Note
Company value at grant (hurdle) £2,000,000 Independent valuation at issue; growth shares participate above this
Exit value (illustrative) £5,000,000 Acquisition or secondary sale three years later
Total uplift above hurdle £3,000,000 £5m minus £2m
Growth share pool (illustrative: 10% of uplift) £300,000 10% of the £3m uplift, split pro rata among growth shareholders
Ordinary shareholders £4,700,000 The hurdle value plus their share of the residual uplift

And what if the exit comes in below the hurdle? If the company sells for £2m or less, the growth shares get nothing, because there's no value above the hurdle to share. The actual split depends on the company's capital structure and the terms of the growth share class, so treat this as the arithmetic of the hurdle, not a forecast.

How growth shares are taxed

Growth shares and unapproved options are taxed under general employment-related-securities rules. Income tax arises on any value acquired above the amount paid at acquisition, with employer and employee National Insurance too where the shares are readily convertible assets (HMRC 480, 23.3). Because the growth shares have a low or nil value at grant (the hurdle structure), the income tax charge at acquisition is correspondingly low.

The critical risk is that if the shares carry restrictions (which they almost always do in practice) and no section 431 election is made, HMRC can charge income tax again when a restriction lifts or the shares are sold while still restricted, on a proportion of what they're worth at that point, not the low grant-date value. That later value could be much higher. The s.431 election (see below) is the mechanism that prevents this.

Unlike EMI or CSOP, there's no statutory scheme behind them: no HMRC-set limit on the value of shares you can issue, and no income tax exemption written into law. What saving there is comes from the low value at grant and the s.431 election.

The section 431 election

Where growth shares carry any restrictions (lock-ups, good-leaver/bad-leaver provisions, transfer restrictions), they are "restricted securities" under Part 7 ITEPA 2003. Without an election, you're taxed on the restricted value when you acquire them, and then again on part of their value each time a restriction lifts or is varied, or when they're sold while still restricted. Those later charges are employment income, worked out on the higher value by then.

A section 431 joint election is made by the employer and the employee together, on a form HMRC approves, within 14 days of acquisition, and it can't be revoked. It means you're taxed on the shares' unrestricted market value at acquisition. At that point the unrestricted value is low (because of the hurdle), so the income tax charge at acquisition is low. All subsequent growth is then treated as a capital gain rather than employment income when the shares are eventually sold.

Missing the 14-day window is an expensive mistake in growth-share structuring, and it's easy to make in the rush of a share issue. Once the window closes, the election can't be made late.

The detailed mechanics of a s.431 election, including the form of the election and the restricted-securities charging provisions it disapplies, are in the section 431 elections guide.

Unapproved options: the alternative

Unapproved options (also called non-tax-advantaged options or general option awards) also fall under general ERS rules. The key structural difference from growth shares is timing: the holder acquires an option to buy shares at a fixed price in the future, rather than acquiring shares now.

Income tax on unapproved options arises at the point of exercise, on the spread between the exercise price and the market value of the shares at that date. NIC is due on that spread only where the shares are readily convertible assets, as they usually are if you exercise as part of a sale (HMRC 480, 23.3). With growth shares and a s.431 election, the income tax event is at acquisition (when the value is low); with unapproved options, the income tax event is at exercise (when the value may be much higher if the company has grown). Both routes then produce a capital gain on disposal measured from the value at which income tax was last charged.

Comparison: growth shares, unapproved options, EMI

Feature Growth shares Unapproved options EMI options
Who can hold Employees, advisers, NEDs, non-employees Employees, advisers, NEDs, non-employees Qualifying employees only (working-time test)
Tax rules General ERS rules General ERS rules Statutory tax-advantaged scheme
Income tax event At acquisition (low value if s.431 made) At exercise (on spread) None at grant or exercise if conditions met
NIC exposure On value above amount paid at acquisition, only if readily convertible assets On spread at exercise (employer and employee), only if readily convertible assets None at exercise if conditions met
s.431 election needed Yes, within 14 days of acquisition At exercise if shares acquired are restricted Deemed made on a market-value EMI exercise (ITEPA s431A); none needed at grant
CGT on disposal 18% / 24%; BADR may apply 18% / 24%; BADR may apply 18% / 24%; BADR easier to meet
Company limits None set by statute None set by statute Gross assets max £120m; fewer than 500 FTE
Tax-advantaged? No No Yes

Sources: ERSM30450 for the general ERS rules; gov.uk EMI guidance for the EMI column. Use the EMI vs unapproved calculator to model the tax difference for a specific scenario.

Calculator

EMI vs Unapproved Options Calculator 2026/27

Enter the option terms and exit value. The tool compares the employee tax cost and the company National Insurance cost across EMI, unapproved options and growth shares at 2026/27 rates. All outputs are general guidance; speak to a specialist before granting or exercising options.

£

The agreed actual market value per share (or per the whole grant) at the date of grant. Used as the EMI base cost and the growth-share starting point.

£

What the employee pays to exercise. For a clean EMI grant, this equals AMV. If below AMV, EMI still produces an income tax charge on the discount.

£

Value of the shares at sale or exit. Unapproved column assumes exercise and sale happen together (cashless exercise). For EMI, this is the disposal proceeds.

Sets where income tax on the unapproved exercise charge starts (20%, 40% or 45%, rising through the bands as the gain grows), and whether CGT starts at 18% (basic rate) or is 24% throughout (higher and additional rate).

£

The unrestricted market value of the growth shares when the employee gets them (usually a low hope value). Defaults to 0. With a s.431 election made within 14 days, income tax at acquisition is on this value less what the employee pays.

£

What the employee pays for the growth shares. Paying the full market value means there's no income tax at acquisition.

Your result

Your answer's ready. Press below to see it.

When growth shares are used instead of EMI

Where a company qualifies, EMI is usually the better route because of its statutory income-tax and NIC exemptions at exercise and the more generous BADR treatment on exit. But EMI qualifying conditions rule it out in several situations:

  • Company size: the company must have gross assets of no more than £120m and fewer than 500 full-time-equivalent employees. A scale-up that has crossed either threshold can't grant new EMI options, though the tests apply at grant, so options it already granted aren't affected.
  • Excluded activities: companies carrying on an excluded activity (such as property development, financial activities, or legal or accountancy services) cannot use EMI, regardless of size.
  • Non-employees: EMI options can only be granted to qualifying employees who meet the working-time test. Advisers, NEDs, consultants and founders who are no longer employees can't be granted EMI options. Growth shares (or unapproved options) are the only share-scheme route for these individuals.

A company that has just tipped over the EMI size thresholds might use CSOP, capped at £60,000 of options per employee (£120,000 from 6 April 2027, if the Budget change becomes law), as a partial bridge before falling back to growth shares. See the EMI qualifying company rules guide and the EMI vs CSOP guide for the full qualifying conditions.

Want this checked against your specific situation?

Leave your details and a one-line summary. One of our specialists will come back to you, with no obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

The exit: CGT and BADR

When growth shares are eventually sold, any gain above the base cost (the unrestricted market value at acquisition, on which income tax was charged at the time of the s.431 election) is a capital gain. CGT on share disposals is charged at 18% within a taxpayer's remaining basic-rate band and 24% above it. These are the current main rates in force since 30 October 2024.

BADR interaction. Business Asset Disposal Relief can reduce the rate to 18% on up to £1m of qualifying lifetime gains (the current rate from 6 April 2026; it was 14% for 2025/26 and 10% before that). From 6 April 2027 the lifetime limit is due to fall from £1 million to £500,000 (announced at Budget 2026 on 28 October 2026, still to pass in the Finance Bill). For ordinary growth shares to qualify for BADR, the standard personal-company test and two-year holding test must be met. The personal-company test typically requires the shareholder to hold at least 5% of the ordinary share capital and voting rights in the company.

EMI option holders can reach BADR without the 5% personal-company test, but that's an EMI feature and it doesn't carry over to growth shares. So do growth shares qualify for BADR? Only if you pass the full test for at least 2 years up to the sale: at least 5% of the shares and 5% of the voting rights, plus at least 5% of either the distributable profits and assets on a winding up or the sale proceeds, while you're an officer or employee of a trading company (gov.uk BADR eligibility). The test looks at your whole holding in the company. Growth shares are often a small, non-voting slice, so on their own they often won't clear it. Whether a given award qualifies comes down to the terms of the share class and the rest of your holding, so pin it down well before the exit rather than assuming.

And Founders' Relief? Founders' Relief is a proposed 10% CGT rate on up to £10 million of gains for disposals from 6 April 2027 (announced at Budget 2026; the conditions are out for consultation until 30 November 2026 and are not yet law). As proposed, it's for people who held at least 25% of the company's ordinary share capital when its trade, or preparation for it, began (HM Treasury consultation), so a growth-share award to a later hire isn't the case it's built for.

What to do next

Growth shares need three things to work correctly: a defensible independent valuation at grant (HMRC won't agree one in advance for growth shares), well-drafted articles and a shareholders' agreement that define the hurdle and the waterfall clearly, and a section 431 election signed by the employer (normally the company) and the employee within 14 days of the shares being issued.

Every growth-share award is also an employment-related-securities event. An ERS return (or nil return) must be filed by 6 July following the end of the tax year in which the award was made, even if the award was low-value or nil-valued. Missing the ERS reporting deadline attracts automatic penalties.

If you're drafting a growth-share plan, weighing it against unapproved options, or just checking your company still clears the EMI tests, the share schemes service runs the whole cycle: valuation, structuring, the s.431 election and the annual ERS return. If you'd rather read first, the option pool basics guide sets the wider context, and the funded-startups hub maps where growth shares sit for companies that have raised.

Frequently asked questions

Growth shares are a separate class of shares that only deliver value above a pre-set hurdle (the current company value at grant). They let employees or advisers share in future growth without paying for the full existing equity value up front.

The hurdle is set at the current market value of the company at the date of grant, backed by an independent valuation done at the time. HMRC Shares and Assets Valuation only agrees values in advance for EMI, CSOP, SAYE and SIP shares, so a growth share valuation has to stand up if HMRC questions it later. Because the shares only participate in value above that hurdle, their market value at grant is very low or nil.

No. Growth shares fall under general ERS rules, not a statutory tax-advantaged scheme. The tax efficiency comes from the low grant value and the s.431 election, not from a statutory wrapper.

Yes, if the shares carry any restrictions. A s.431 joint election must be made within 14 days of acquisition and causes you to be taxed on unrestricted market value at acquisition rather than on a restricted (lower) value, so that all future growth is treated as a capital gain rather than employment income. Source: gov.uk ERSM30450.

When the company has gross assets over £120m, 500 or more FTE, operates in an excluded activity, or wants to make an award to someone who cannot hold EMI options (for example an adviser, NED or non-employee). Source: gov.uk/tax-employee-share-schemes/enterprise-management-incentives-emis.

CGT at 18% within the basic-rate band and 24% above it. BADR may apply at 18% where the standard personal-company and two-year tests are met, but the EMI-specific BADR concession (which waives the 5% personal-company test) does not extend to ordinary growth shares. Sources: gov.uk/capital-gains-tax/rates and gov.uk/business-asset-disposal-relief.

Yes. This is one of the main reasons to use growth shares rather than EMI options. EMI is restricted to qualifying employees; growth shares can be awarded to advisers, NEDs and consultants, though the tax treatment on exit depends on the nature of the relationship.

Need specialist startup tax advice?

Speak to an accountant who works with funded and scaling UK startups. R&D relief, SEIS/EIS, EMI, founder salary and dividend planning.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)

Related reading